Back
Relmada Therapeutics, Inc. Stock Price Chart
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
34
RLMD
Relmada Therapeutics, Inc.
Last Price:
$3.79
Seasonality Move:
-2.79%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
The current trend is moderately bullish and RLMD is experiencing selling pressure, which indicates risk of future bearish movement.
Relmada Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.17 | Sell |
| 20-day SMA: | 4.33 | Sell |
| 50-day SMA: | 3.99 | Sell |
| 200-day SMA: | 1.71 | Buy |
| 8-day EMA: | 4.12 | Sell |
| 20-day EMA: | 3.56 | Buy |
| 50-day EMA: | 2.21 | Buy |
| 200-day EMA: | 0.71 | Buy |
Relmada Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.8 | Buy |
| Relative Strength Index (14 RSI): | 41.93 | Sell |
| Chaikin Money Flow: | -214116 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.09 - 4.53) | Sell |
| Bollinger Bands (100): | (1.61 - 4.13) | Buy |
Relmada Therapeutics, Inc. Technical Analysis
| Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 30 | 31 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Relmada Therapeutics, Inc. Stock
Is Relmada Therapeutics, Inc. Stock a Buy?
-
Relmada Therapeutics, Inc. share price is 3.84 while RLMD 8-day simple moving average is 4.17, which is a Sell signal.
-
The stock price of RLMD is 3.84 while Relmada Therapeutics, Inc. 20-day SMA is 4.33, which makes it a Sell.
-
Relmada Therapeutics, Inc. 50-day simple moving average is 3.99 while RLMD share price is 3.84, making it a Sell technically.
-
RLMD stock price is 3.84 and Relmada Therapeutics, Inc. 200-day simple moving average is 1.71, creating a Buy signal.
RLMD Technical Analysis vs Fundamental Analysis
Sell
34
Relmada Therapeutics, Inc. (RLMD)
is a Sell
Is Relmada Therapeutics, Inc. a Buy or a Sell?
-
Relmada Therapeutics, Inc. stock is rated a SellThe current Relmada Therapeutics, Inc. [RLMD] share price is $3.84. The Score for RLMD is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Relmada Therapeutics, Inc. Stock Info
Market Cap:
281.6M
Price in USD:
3.84
Share Volume:
414K
Relmada Therapeutics, Inc. 52-Week Range
52-Week High:
5.12
52-Week Low:
0.24
Sell
34
Relmada Therapeutics, Inc. (RLMD)
is a Sell
Relmada Therapeutics, Inc. Share Price Forecast
-
What is the Relmada Therapeutics, Inc. stock price today?The Relmada Therapeutics, Inc. stock price is 3.84 USD today.
-
Will RLMD stock go up or go down?Relmada Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Relmada Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Relmada Therapeutics, Inc. is overvalued.
Is Relmada Therapeutics, Inc. Stock a Buy?
-
Relmada Therapeutics, Inc. share price is 3.84 while RLMD 8-day exponential moving average is 4.12, which is a Sell signal.
-
The stock price of RLMD is 3.84 while Relmada Therapeutics, Inc. 20-day EMA is 3.56, which makes it a Buy.
-
Relmada Therapeutics, Inc. 50-day exponential moving average is 2.21 while RLMD share price is 3.84, making it a Buy technically.
-
RLMD stock price is 3.84 and Relmada Therapeutics, Inc. 200-day simple moving average is 0.71, creating a Buy signal.
Fundamental Analysis of Relmada Therapeutics, Inc.
Is Relmada Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and a decrease next year of $0.10 per share.
Technical Analysis of Relmada Therapeutics, Inc.
Should I short Relmada Therapeutics, Inc. stock?
-
RLMD Moving Average Covergence Divergence (MACD) indicator is 0.8, suggesting Relmada Therapeutics, Inc. is a Buy
-
Relmada Therapeutics, Inc. Relative Strength Index (RSI) is 41.93, which suggest Relmada Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Relmada Therapeutics, Inc. is (4.09 - 4.53), which suggest Relmada Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Relmada Therapeutics, Inc. is (1.61 - 4.13), which suggest Relmada Therapeutics, Inc. is a Buy
* Relmada Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.